BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1293477)

  • 1. [Acetylation phenotype as a biomarker of sensitivity to the carcinogenic effect of aromatic amines].
    Indulski JA; Krajewska B; Lutz W
    Med Pr; 1992; 43(5):427-35. PubMed ID: 1293477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [N-acetylation polymorphism versus differentiation of organic susceptibility to carcinogenic effect of homo- and heterocyclic aromatic amines].
    Lutz W; Barański B; Krajewska B
    Med Pr; 1994; 45(4):343-9. PubMed ID: 7968503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines].
    Hanke J; Krajewska B; Lutz W
    Med Pr; 1989; 40(6):376-80. PubMed ID: 2698439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of bladder cancer.
    Vineis P; Martone T
    Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological models of carcinogenesis: the example of bladder cancer.
    Vineis P
    Cancer Epidemiol Biomarkers Prev; 1992; 1(2):149-53. PubMed ID: 1306098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aromatic amines, oncogenes and cancer of the bladder].
    Lutz W; Krajewska B
    Med Pr; 1991; 42(6):477-84. PubMed ID: 1808456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation phenotypes and bladder cancer.
    Hanke J; Krajewska B
    J Occup Med; 1990 Sep; 32(9):917-8. PubMed ID: 2074519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
    Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
    Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
    Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines.
    Yasunaga Y; Nakanishi H; Naka N; Miki T; Tsujimura T; Itatani H; Okuyama A; Aozasa K
    Lab Invest; 1997 Dec; 77(6):677-84. PubMed ID: 9426406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the levels of tissue polypeptide antigen and carcinoembryonic antigen in the blood of workers exposed to aromatic amines].
    Lutz W; Krajewska B
    Med Pr; 1992; 43(4):297-301. PubMed ID: 1453945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific aromatic amines as occupational bladder carcinogens.
    Clayson DB
    Natl Cancer Inst Monogr; 1981 Dec; (58):15-9. PubMed ID: 7341971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological monitoring of risk of bladder cancer in persons occupationally exposed to aromatic amines.
    Indulski JA; Lutz W
    Pol J Occup Med Environ Health; 1992; 5(2):143-51. PubMed ID: 1392660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.
    Talaska G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2003 May; 21(1):29-43. PubMed ID: 12826031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany.
    Golka K; Prior V; Blaszkewicz M; Cascorbi I; Schöps W; Kierfeld G; Roots I; Bolt HM
    Scand J Work Environ Health; 1996 Oct; 22(5):332-8. PubMed ID: 8923605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More on adducts and addicts. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.
    Coggon D
    Hum Exp Toxicol; 1995 Jun; 14(6):538-9. PubMed ID: 8519531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Occupational exposure and bladder cancer].
    Conso F
    Rev Prat; 2004 Oct; 54(15):1665-70. PubMed ID: 15605580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic acetylator phenotype in bladder cancer patients.
    Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
    Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary mutagenicity and N-acetylation phenotype in textile industry workers exposed to arylamines.
    Sinués B; Pérez J; Bernal ML; Sáenz MA; Lanuza J; Bartolomé M
    Cancer Res; 1992 Sep; 52(18):4885-9. PubMed ID: 1516045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of exposure and susceptibility to aromatic amine carcinogens.
    Kadlubar FF; Talaska G; Lang NP; Benson RW; Roberts DW
    IARC Sci Publ; 1988; (89):166-74. PubMed ID: 3198199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.